A recent focused study on anaplastic large-cell lymphomas (ALCLs) expressing the oncogenic fusion kinase NPM-ALK, identified NPM-ALK targeted phosphorylation sites on nuclear interaction partner of ALK (NIPA) which promote lymphomagenesis when phosphorylated [306]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.